Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Coherus Oncology (CHRS) Interest Coverage Ratio (2016 - 2025)

Coherus Oncology's Interest Coverage Ratio history spans 12 years, with the latest figure at 20.4 for Q4 2025.

  • For Q4 2025, Interest Coverage Ratio rose 14.06% year-over-year to 20.4; the TTM value through Dec 2025 reached 20.12, down 58.51%, while the annual FY2025 figure was 20.12, 8.19% down from the prior year.
  • Interest Coverage Ratio for Q4 2025 was 20.4 at Coherus Oncology, down from 19.07 in the prior quarter.
  • Across five years, Interest Coverage Ratio topped out at 3.12 in Q3 2023 and bottomed at 51.47 in Q3 2021.
  • The 5-year median for Interest Coverage Ratio is 8.88 (2024), against an average of 14.31.
  • The largest YoY upside for Interest Coverage Ratio was 79.47% in 2021 against a maximum downside of 963.45% in 2021.
  • A 5-year view of Interest Coverage Ratio shows it stood at 6.83 in 2021, then increased by 19.63% to 5.49 in 2022, then dropped by 18.26% to 6.49 in 2023, then tumbled by 265.8% to 23.74 in 2024, then grew by 14.06% to 20.4 in 2025.
  • Per Business Quant, the three most recent readings for CHRS's Interest Coverage Ratio are 20.4 (Q4 2025), 19.07 (Q3 2025), and 19.98 (Q2 2025).